Tekla Capital Management LLC Insmed Inc Transaction History

Tekla Capital Management LLC

  • $2.53 Billion
  • Q2 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$22.46 - $29.47 $2.21 Million - $2.9 Million
-98,387 Closed
0 $0
Q1 2020

May 14, 2020
SELL
$13.63 - $33.98 $905,018 - $2.26 Million
-66,399 Reduced 40.29%
98,387 $1.58 Million
Q3 2019

Nov 13, 2019
BUY
$15.49 - $25.78 $2.55 Million - $4.25 Million
164,786 New
164,786 $2.91 Million

Others Institutions Holding INSM

# of Institutions
447
Shares Held
170M
Call Options Held
5.79M
Put Options Held
5.18M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.82B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email